Two years after World Health Assembly Resolution 72.8 was agreed on improving the transparency of markets for medicines, vaccines and other health products, WHO/Europe has released a report identifying and summarizing the current evidence on the implementation of transparency measures in the WHO European Region. This follows intense debate over the roles and responsibilities of the public and private sectors in the development of vaccines for COVID-19.
